Targeting PDZ Binding Kinase Is Anti-tumorigenic in Novel Preclinical Models of ACC

Adrenocortical carcinoma (ACC) is an aggressive orphan malignancy with less than 35% 5-year survival and 75% recurrence. Surgery remains the primary therapy and Mitotane, an adrenolytic, is the only FDA approved drug with wide range toxicities and poor tolerability. There are no targeted agents avai...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Endocr Relat Cancer
Asıl Yazarlar: Kar, Adwitiya, Zhang, Yu, Yacob, Betelehem W., Saeed, Jordan, Tompkins, Kenneth D., Bagby, Stacey M., Pitts, Todd M., Somerset, Hilary, Leong, Stephen, Wierman, Margaret E., Kiseljak-Vassiliades, Katja
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6938568/
https://ncbi.nlm.nih.gov/pubmed/31325906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0262
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller